TY - JOUR
T1 - Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency
AU - Graves, Penelope E.
AU - Fenster, Paul E.
AU - MacFarland, Ronald T.
AU - Marcus, Frank I.
AU - Perrier, Donald
PY - 1984/11
Y1 - 1984/11
N2 - The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1 2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.
AB - The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1 2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.
UR - http://www.scopus.com/inward/record.url?scp=0021686487&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021686487&partnerID=8YFLogxK
U2 - 10.1038/clpt.1984.229
DO - 10.1038/clpt.1984.229
M3 - Article
C2 - 6488681
AN - SCOPUS:0021686487
SN - 0009-9236
VL - 36
SP - 607
EP - 612
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
IS - 5
ER -